344 related articles for article (PubMed ID: 14739303)
1. Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways.
Han KJ; Su X; Xu LG; Bin LH; Zhang J; Shu HB
J Biol Chem; 2004 Apr; 279(15):15652-61. PubMed ID: 14739303
[TBL] [Abstract][Full Text] [Related]
2. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
3. PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis.
Zhang J; Xu LG; Han KJ; Wei X; Shu HB
FEBS Lett; 2004 Jul; 570(1-3):97-101. PubMed ID: 15251447
[TBL] [Abstract][Full Text] [Related]
4. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.
Lin R; Yang L; Nakhaei P; Sun Q; Sharif-Askari E; Julkunen I; Hiscott J
J Biol Chem; 2006 Jan; 281(4):2095-103. PubMed ID: 16306043
[TBL] [Abstract][Full Text] [Related]
6. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
Wang YY; Li L; Han KJ; Zhai Z; Shu HB
FEBS Lett; 2004 Oct; 576(1-2):86-90. PubMed ID: 15474016
[TBL] [Abstract][Full Text] [Related]
7. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif.
Kaiser WJ; Offermann MK
J Immunol; 2005 Apr; 174(8):4942-52. PubMed ID: 15814722
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
10. The TRIF/TBK1/IRF-3 activation pathway is the primary inhibitory target of resveratrol, contributing to its broad-spectrum anti-inflammatory effects.
Kim MH; Yoo DS; Lee SY; Byeon SE; Lee YG; Min T; Rho HS; Rhee MH; Lee J; Cho JY
Pharmazie; 2011 Apr; 66(4):293-300. PubMed ID: 21612158
[TBL] [Abstract][Full Text] [Related]
11. Poxvirus protein N1L targets the I-kappaB kinase complex, inhibits signaling to NF-kappaB by the tumor necrosis factor superfamily of receptors, and inhibits NF-kappaB and IRF3 signaling by toll-like receptors.
DiPerna G; Stack J; Bowie AG; Boyd A; Kotwal G; Zhang Z; Arvikar S; Latz E; Fitzgerald KA; Marshall WL
J Biol Chem; 2004 Aug; 279(35):36570-8. PubMed ID: 15215253
[TBL] [Abstract][Full Text] [Related]
12. Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon.
Civas A; Génin P; Morin P; Lin R; Hiscott J
J Biol Chem; 2006 Feb; 281(8):4856-66. PubMed ID: 16380379
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-kappa B activation and IFN-beta synthesis downstream of Toll-like receptor 3 and 4.
Aksoy E; Vanden Berghe W; Detienne S; Amraoui Z; Fitzgerald KA; Haegeman G; Goldman M; Willems F
Eur J Immunol; 2005 Jul; 35(7):2200-9. PubMed ID: 15940673
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
15. Homo-oligomerization is essential for Toll/interleukin-1 receptor domain-containing adaptor molecule-1-mediated NF-kappaB and interferon regulatory factor-3 activation.
Funami K; Sasai M; Oshiumi H; Seya T; Matsumoto M
J Biol Chem; 2008 Jun; 283(26):18283-91. PubMed ID: 18450748
[TBL] [Abstract][Full Text] [Related]
16. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
[TBL] [Abstract][Full Text] [Related]
17. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
18. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
[TBL] [Abstract][Full Text] [Related]
19. A20 is a negative regulator of IFN regulatory factor 3 signaling.
Saitoh T; Yamamoto M; Miyagishi M; Taira K; Nakanishi M; Fujita T; Akira S; Yamamoto N; Yamaoka S
J Immunol; 2005 Feb; 174(3):1507-12. PubMed ID: 15661910
[TBL] [Abstract][Full Text] [Related]
20. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription.
Buss H; Dörrie A; Schmitz ML; Hoffmann E; Resch K; Kracht M
J Biol Chem; 2004 Dec; 279(53):55633-43. PubMed ID: 15489227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
